Beverly Livingston beverlylivings
  • Chicoutimi
  • http://123.57.146.97:3000/shannanrosenst
  • In a phase 2 study, the medication showed up to 20% average weight loss at 52 weeks for people with obesity or overweight without diabetes and 17% for those with overweight/obesity and type 2 diabetes.

  • Joined on 2026-04-01
Updated 2026-04-01 15:14:38 +02:00